Status:
UNKNOWN
IL35 Level in Vitiligo
Lead Sponsor:
Cairo University
Conditions:
IL35, Vitiligo
Eligibility:
All Genders
18-60 years
Brief Summary
The aim of this observational study is to evaluate the level of the IL-35 protein in tissue biopsy from patients with active \& stable vitiligo.
Eligibility Criteria
Inclusion
- Patients with active and stable vitiligo
Exclusion
- Pregnant and lactating women.
- Patients with associated autoimmune or other dermatological diseases e.g., Alopecia areata and lupus erythematous.
- Patients already on both topical and systemic treatment at the time of recruitment.
- Patients on Immunosuppressive drugs.
- Other hypopigmented diseases such as pityriasis alba, tinea versicolor, lichen sclerosis, post inflammatory hypopigmentation and leprosy as excluded by lack of accentuation by wood's light examination.
Key Trial Info
Start Date :
August 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05980390
Start Date
August 10 2023
End Date
October 30 2023
Last Update
August 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.